SOURCE: Industrial Info Resources

October 01, 2007 06:02 ET

To Build or Not to Build? How Many Pharma-Biotech Capital Projects Actually Make Construction?, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - October 1, 2007) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- When considering reported pharmaceutical-biotech capital project spending for any given year, it is important to analyze what becomes of the projects after they are first reported. Utilizing analysis tools, such as Gap Measurement and Project Fallout, help to illuminate an accurate view of project-spending patterns.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=120372, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) provides marketing communication services ranging from industrial database solutions to market forecasting, custom analytics, and specialty promotions that support high-level image campaigns. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Contact Information

  • Contact:
    Joe Govreau
    713-783-5147